Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria

Ani Kardashian, Sander S. Florman, Brandy Haydel, Richard M. Ruiz, Goran B. Klintmalm, David D. Lee, C. Burcin Taner, Federico Aucejo, Amit D. Tevar, Abhinav Humar, Elizabeth C. Verna, Karim J. Halazun, William C. Chapman, Neeta Vachharajani, Maarouf Hoteit, Matthew H. Levine, Mindie H. Nguyen, Marc L. Melcher, Alan N. Langnas, Carol A. Carney, Constance Mobley, Mark Ghobrial, Beth Amundsen, James F. Markmann, Debra L. Sudan, Christopher M. Jones, Jennifer Berumen, Alan W. Hemming, Johnny C. Hong, Joohyun Kim, Michael A. Zimmerman, Trevor L. Nydam, Abbas Rana, Michael L. Kueht, Thomas M.

Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring, Sergio E. Rojter, Zeid Kayali, Vincent Wai‐Sun Wong, Susan Greenbloom, Saumya Jayakumar, Mitchell L. Shiffman, Bradley Freilich, Eric J. Lawitz, Edward J. Gane, Eliza Harting, Jun Xu, Andrew N. Billin, Chuhan Chung, C. Stephen Djedjos, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Mary Rinella, Mazen Noureddin – 1 March 2020

Subscribe to